These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 3025417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anoxic contractions in isolated canine cerebral arteries: contribution of endothelium-derived factors, metabolites of arachidonic acid, and calcium entry.
    Katusic ZS, Vanhoutte PM.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S97-101. PubMed ID: 2433536
    [Abstract] [Full Text] [Related]

  • 3. Adenine nucleotides and 5-hydroxytryptamine released by aggregating platelets inhibit adrenergic neurotransmission in canine coronary artery.
    Cohen RA.
    J Clin Invest; 1986 Feb; 77(2):369-75. PubMed ID: 3003158
    [Abstract] [Full Text] [Related]

  • 4. Beta-2 adrenergic responses to tulobuterol in airway smooth muscle, vascular smooth muscle and adrenergic nerves.
    Ruff F, Zander JF, Edoute Y, Santais MC, Flavahan NA, Verbeuren TJ, Vanhoutte PM.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):173-80. PubMed ID: 2826765
    [Abstract] [Full Text] [Related]

  • 5. Platelet-induced neurogenic coronary contractions due to accumulation of the false neurotransmitter, 5-hydroxytryptamine.
    Cohen RA.
    J Clin Invest; 1985 Jan; 75(1):286-92. PubMed ID: 3965509
    [Abstract] [Full Text] [Related]

  • 6. Pharmacology of pentoxifylline in isolated canine arteries and veins.
    Hoeffner U, Aarhus LL, Katusic ZS, Vanhoutte PM.
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):899-907. PubMed ID: 2481780
    [Abstract] [Full Text] [Related]

  • 7. Pharmacology of bucindolol in isolated canine vascular smooth muscle.
    Rimele TJ, Aarhus LL, Lorenz RR, Rooke TW, Vanhoutte PM.
    J Pharmacol Exp Ther; 1984 Nov; 231(2):317-25. PubMed ID: 6149305
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of constriction of cerebral arterioles in vivo by naftidrofuryl. Action against serotonin and dinoprost.
    Rosenblum WI.
    Arzneimittelforschung; 1987 May; 37(5):495-7. PubMed ID: 3476118
    [Abstract] [Full Text] [Related]

  • 9. Prejunctional beta-adrenoceptors in human and canine saphenous veins.
    Verbeuren TJ, Lorenz RR, Aarhus LL, Shepherd JT, Vanhoutte PM.
    J Auton Nerv Syst; 1983 Jul; 8(3):261-71. PubMed ID: 6321585
    [Abstract] [Full Text] [Related]

  • 10. Prejunctional adrenergic inhibition by aggregating platelets in canine blood vessels.
    Lorenz RR, Vanhoutte PM.
    Am J Physiol; 1985 Sep; 249(3 Pt 2):H685-9. PubMed ID: 4037113
    [Abstract] [Full Text] [Related]

  • 11. Inorganic phosphate inhibits sympathetic neurotransmission in canine saphenous veins.
    Edoute Y, Vanhoutte PM, Shepherd JT.
    Am J Physiol; 1987 Jan; 252(1 Pt 2):H131-4. PubMed ID: 3028159
    [Abstract] [Full Text] [Related]

  • 12. Interaction between alpha adrenergic and serotonergic activation of canine saphenous veins.
    Curro FA, Greenberg S, Verbeuren TJ, Vanhoutte PM.
    J Pharmacol Exp Ther; 1978 Dec; 207(3):936-49. PubMed ID: 215746
    [Abstract] [Full Text] [Related]

  • 13. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
    Cohen ML, Schenck KW, Hemrick-Luecke SH.
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of adrenergic neurotransmission in canine tibial artery after exposure to 5-hydroxytryptamine in vitro.
    Cohen RA.
    J Pharmacol Exp Ther; 1987 Aug; 242(2):493-9. PubMed ID: 3039118
    [Abstract] [Full Text] [Related]

  • 15. Cyclic GMP modulators on vascular adrenergic neurotransmission.
    Tesfamariam B, Weisbrod RM, Cohen RA.
    J Vasc Res; 1992 Aug; 29(5):396-404. PubMed ID: 1358232
    [Abstract] [Full Text] [Related]

  • 16. Effect of CRL 41034 on the adrenergic neuroeffector interaction in the canine saphenous vein.
    Boulanger C, Flavahan NA, Katusic ZS, Komori K, Vos AA, Vanhoutte PM.
    Fundam Clin Pharmacol; 1990 Aug; 4(5):525-38. PubMed ID: 1981202
    [Abstract] [Full Text] [Related]

  • 17. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
    Cohen RA.
    J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
    [Abstract] [Full Text] [Related]

  • 18. Inhibitors of prostaglandin synthesis augment beta-adrenergic responsiveness in canine coronary arteries.
    Rubanyi G, Vanhoutte PM.
    Circ Res; 1985 Jan; 56(1):117-25. PubMed ID: 2981646
    [Abstract] [Full Text] [Related]

  • 19. The effect of naftidrofuryl on PGF2 alpha, U 46.619, 5-HT and thromboxane A2 (TXA2) induced vasoconstriction.
    Verheggen R, Schrör K.
    Biomed Biochim Acta; 1988 Jan; 47(10-11):S264-7. PubMed ID: 3248112
    [Abstract] [Full Text] [Related]

  • 20. Effect of vibration on a canine cutaneous artery.
    Lindblad LE, Lorenz RR, Shepherd JT, Vanhoutte PM.
    Am J Physiol; 1986 Mar; 250(3 Pt 2):H519-23. PubMed ID: 3456723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.